• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Donate Now
  • Sign Up

Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

  • Eligibility/Enrollment
  • Coverage/Appeals
    • Medicare Costs (2021)
    • Self Help Materials – Toolkits & More
  • Topics
    • Basic Introduction to Medicare
    • COVID-19 and Medicare
    • Medicare Costs (2021)
    • Home Health Care
    • Improvement Standard and Jimmo News
    • Nursing Home / Skilled Nursing Facility Care
    • Outpatient Observation Status
    • Part B
    • Part D / Prescription Drug Benefits
    • Medicare for People Under 65
    • Medicare “Reform”
    • All Other Topics
    • Resources
      • Infographics
  • Publications
    • CMA Alerts
    • Fact Sheets & Issue Briefs
    • Infographics
    • The Medicare Handbook
    • SNF Enforcement Newsletter
    • Elder Justice Newsletter
    • Medicare Facts & Fiction
    • Articles by Topic
  • Litigation
    • Litigation News
    • Cases
    • Litigation Archive
    • Amicus Curiae Activities
  • Newsroom
    • Press Releases
    • Editorials & Letters to the Editor
    • CMA Comments, Responses, and Letters
    • Medicare Facts & Fiction
    • CMA in the News
  • About Us
    • Mission Statement
    • CMA FAQs
    • Annual Report
    • Personnel & Boards
    • The Center for Medicare Advocacy Founder’s Circle
    • Connecticut Dually Eligible Appeals Project
    • Ossen Medicare Outreach, Education and Advocacy Project
    • National Medicare Advocates Alliance
    • National Voices of Medicare Summit
    • CMA Webinars
    • Products & Services
    • Testimonials
    • Career, Fellowship & Internship Opportunities
    • Contact Us
  • Support Our Work
    • Donate Now
    • Join the Center for Medicare Advocacy Founder’s Circle
    • Take Action
    • Share Your Health Care Story
    • Tell Congress to Protect Our Care
    • Listen to Medicare & Health Care Stories
    • Sign Up

Medicare Prescription Drug Rebate Debate

November 21, 2013

Print Friendly, PDF & Email

The Medicare Part D Prescription drug program is forbidden by law from getting the best prices for prescription drugs. Unlike the Veterans Administration and Medicaid, Medicare is at the mercy of drug company pricing, forbidden from seeking lower prices for its enrollees.

Allowing Medicare to get fair drug prices would save billions of taxpayer dollars a year, without hurting beneficiary access to medication.

The Medicare Drug Savings Act of 2013,[1]  introduced by Senator Jay Rockefeller and 18 others, is a common sense, cost-effective way to save the Medicare program more than $141 billion. It would allow Medicare to obtain lower drug prices on behalf of low-income Medicare beneficiaries without cutting benefits.[2]

The savings produced by the Medicare Drug Savings Act can and should be used to pay for the cost of reforming the Sustainable Growth Rate, also known as the "Doc Fix". The Sustainable Growth Rate is an unfair Medicare physician payment scheme which must be addressed by Congress every year. Enacting a permanent fix and ensuring that Medicare physicians are paid fairly will not be cheap. However, the savings from the Drug Savings Act would be enough to correct this flawed formula once and for all.

The pharmaceutical industry and those with whom they have influence are fighting the proposed legislation, claiming it will limit innovation and force drug manufacturers to increase prices. This simply isn't true.[3]  The truth is that allowing Medicare to get fair drug prices will cut into the pharmaceutical industry's astronomical profit margin.[4]

At a time when legislators and special interests are trying to dismantle Medicare, or "reform" it on the backs of those who rely on it the most, this is a plan for savings that works.  

For more information, see the links below:

  • Issue Brief – Medicare Drug Negotiation and Rebates (NCPSSM)
  • Fact Sheet – Medicare Prescription Drug Pricing (Office of Sen. Rockefeller)
  • Fact Sheet – the "We Need the Money for Research and Development" Argument (Office of Sen. Rockefeller)
  • Fact Sheet – Rebates and the SGR Fix (Office of Sen. Rockefeller)
  • How to Respond to the Industries Arguments that Rebates will Shift Costs to Consumers (HCAN)
  • Rebates v. MORE Beneficiary Cost Sharing, What Would you Choose? (ARA)
  • Restoring What Works: Restoring Medicare Drug Rebates (LCAO)
  • Advocacy Groups Sign-On Letter to Congress
  • Article: "How Medicare Can Save Big Dollars on Drug Costs," John F. Wasik/Medicare NewsGroup – June 4, 2013

[1] http://thomas.loc.gov/cgi-bin/bdquery/z?d113:SN00740
[2] See floor statement of Sen. Rockefeller at: https://www.medicareadvocacy.org/wp-content/uploads/2013/11/FLOOR-STATEMENT-Medicare-Drug-Savings-Act-of-2013.pdf
[3] See "The Medicare Drug Savings Act of 2013 Will Not Result in Cost-Shifting," Health Care for America Now, july 2013 at: https://www.medicareadvocacy.org/wp-content/uploads/2013/11/How-to-respond-to-cost-shift-arguments-re-rebate-bill-2013-0712i.pdf
[4] See "Big Pharma Pockets $711 Billion in Profits by Price-Gouging taxpayers and Seniors," Health Care for America Now, April 2013 at: http://healthcareforamericanow.org/2013/04/08/pharma-711-billion-profits-price-gouging-seniors/

 

Filed Under: Article Tagged With: Medicare and Health Care Reform, Medicare and Health Reform, Medicare Part D / Prescription Drugs

Primary Sidebar

Easy Access to Understanding Medicare

The Center for Medicare Advocacy produces a range of informative materials on Medicare-related topics. Check them out:

  • Medicare Basics
  • CMA Alerts
  • CMA Webinars
  • Connecticut Info & Projects
  • Health Care Stories
  • Se habla Español

Sign Up for CMA Alerts

Jimmo v. Sebelius

Medicare covers skilled care to maintain or slow decline as well as to improve.

Improvement Isn’t Required. It’s the law!

Read more.

Medicare: Build Back Better

By prioritizing Medicare beneficiaries and the health systems that serve them, we can avoid drastic national consequences. The Center for Medicare Advocacy proposes a five-part plan that will make Medicare a bulwark against the worsening health and economic challenges facing the American people.

Learn more.

Latest Tweets

  • Special thanks from @CMAorg to @PowersLawFirm for the many years of ongoing support and for sponsoring our recent N… https://t.co/8z36yJHyQd, 10 hours ago
@CMAorg

Footer

Stay Connected:

  • Contact Us
  • Sitemap
  • Products & Services
  • Copyright/Privacy

© 2021 · Center for Medicare Advocacy